ICU Medical Inc. (NASDAQ:ICUI) Director Richard Md Sherman sold 3,000 shares of ICU Medical stock in a transaction on Monday, September 19th. The shares were sold at an average price of $122.51, for a total value of $367,530.00. Following the transaction, the director now owns 70,699 shares of the company’s stock, valued at approximately $8,661,334.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

ICU Medical Inc. (NASDAQ:ICUI) opened at 125.48 on Thursday. ICU Medical Inc. has a 1-year low of $85.56 and a 1-year high of $128.93. The stock has a 50 day moving average price of $123.56 and a 200 day moving average price of $109.63. The stock has a market cap of $2.02 billion, a PE ratio of 37.37 and a beta of 0.49.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Monday, August 8th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.10. The firm had revenue of $96.70 million for the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The company’s quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.97 earnings per share. On average, analysts predict that ICU Medical Inc. will post $4.54 EPS for the current fiscal year.

A number of brokerages have issued reports on ICUI. Piper Jaffray Cos. reiterated a “neutral” rating and set a $119.00 price objective (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $141.00 price objective for the company in a research note on Wednesday.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC acquired a new position in ICU Medical during the second quarter worth approximately $124,000. Bank of Montreal Can acquired a new position in ICU Medical during the second quarter worth approximately $133,000. PineBridge Investments L.P. boosted its position in ICU Medical by 3.6% in the second quarter. PineBridge Investments L.P. now owns 1,835 shares of the company’s stock worth $207,000 after buying an additional 63 shares in the last quarter. Amalgamated Bank acquired a new position in ICU Medical during the second quarter worth approximately $214,000. Finally, M&T Bank Corp boosted its position in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares in the last quarter. 89.50% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

5 Day Chart for NASDAQ:ICUI

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.